Randomised clinical trial: deep remission in biologic and immunomodulator naïve patients with Crohn's disease – a SONIC post hoc analysis

Publisher： John Wiley & Sons Inc

E-ISSN： 1365-2036|41|8|734-746

ISSN： 0269-2813

Source： ALIMENTARY PHARMACOLOGY & THERAPEUTICS, Vol.41, Iss.8, 2015-04, pp. : 734-746

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Editorial: post hoc analysis of SONIC trial

By  

ALIMENTARY PHARMACOLOGY & THERAPEUTICS, Vol. 41, Iss. 11, 2015-06 ,pp. : 1210-1210

John Wiley & Sons Inc

Access to resources Recommend Favorite

Editorial: post hoc analysis of SONIC trial – authors’ reply

By  

ALIMENTARY PHARMACOLOGY & THERAPEUTICS, Vol. 41, Iss. 11, 2015-06 ,pp. : 1211-1211

John Wiley & Sons Inc

Access to resources Recommend Favorite

Comparison of infliximab with adalimumab in 827 biologic‐naïve patients with Crohn's disease: a population‐based Danish cohort study

By  

ALIMENTARY PHARMACOLOGY & THERAPEUTICS, Vol. 47, Iss. 5, 2018-03 ,pp. : 596-604

John Wiley & Sons Inc

Access to resources Recommend Favorite

Effects of hydroxyethyl starch in subgroups of patients with severe sepsis: exploratory post-hoc analyses of a randomised trial

By Müller Rasmus   Haase Nicolai   Wetterslev Jørn   Perner Anders  

Intensive Care Medicine, Vol. 39, Iss. 11, 2013-11 ,pp. : 1963-1971

Springer Publishing Company

Access to resources Recommend Favorite

Once‐daily oxybutynin patch improves nocturia and sleep quality in Japanese patients with overactive bladder: Post‐hoc analysis of a phase III randomized clinical trial

By  

INTERNATIONAL JOURNAL OF UROLOGY, Vol. 22, Iss. 7, 2015-07 ,pp. : 684-688

John Wiley & Sons Inc

Access to resources Recommend Favorite